Huaizhong Hu

Biography

  Dr. Huaizhong Hu joined CANbridge in July, 2016.  He brings to CANbridge nearly 30 years of combined experiences in industry, academia and clinical medicine.  Prior to CANbridge Dr. Hu spent 10 years at Covance Laboratory and held senior scientific positions as Toxicology Senior Study Director, Immuno-toxicology Lead Scientist at Covance U.S. and most recently Early Development Scientific Director at Covance China.  During his tenure Dr. Hu led or supervised over 200 GLP/non-GLP toxicology or immune-toxicology studies.  Between 2000-2007, Dr. Hu was R&D Director at Renorvar where he led the team and effort that developed biomarkers and diagnostic tests for immunological diseases.  Dr. Hu was a Lee Kuan Yew Research Fellow and Principal Investigator at Department of Microbiology and Faculty of Medicine at National University of Singapore.  He received his Medical Degree from West China University of Medical Sciences and subsequently practiced medicine for 3 years in Clinical Immunology at the First Affiliated University Hospital.  Dr. Hu holds a Ph.D. in T cell immunology from Utrecht University.  He was a Postdoctoral Fellow in immunology and toxicology at the NIH where he successfully cloned and functionally evaluated a recombinant immunotoxin that has been developed and tested in a Phase II clinical trial for skin T cell lymphoma.  He co-authored over 50 publications in peer-reviewed international journals and is an inventor on close to 20 U.S., European and Chinese issued or pending patents.  

Research Interest

Clinical Immunology,toxicology